Search research articles
Contact Us
Filters
Showing results (111-120 of 237) with videos related to
Page
of 24
Sort By:
Journal of Computer-Aided Molecular Design
|
October 5, 2020
Covalent inhibitor reactivity prediction by the electrophilicity index-in and out of scope
Markus R Hermann, Alexander Pautsch, Marc A Grundl, et al.
Carcinogenesis
|
July 30, 1999
Strong nasal carcinogenicity and genotoxicity of 1-nitroso-4-methylpiperazine after low dose inhalation in rats
R G Klein, P Schmezer, R Hermann, et al.
The Journal of Physical Chemistry Letters
|
January 18, 2020
Small-Angle X-ray Scattering Curves of Detergent Micelles: Effects of Asymmetry, Shape Fluctuations, Disorder, and Atomic Details
Miloš T Ivanović, Markus R Hermann, Maciej Wójcik, et al.
Applied and Environmental Microbiology
|
June 1, 2000
Methods for intense aeration, growth, storage, and replication of bacterial strains in microtiter plates
W A Duetz, L Rüedi, R Hermann, et al.
Bollettino Chimico Farmaceutico
|
July 1, 1995
HPLC method for the quantitation of cispentacin enantiomers in rat urine
M Zanol, R Hermann, A Bernareggi, et al.
International Journal of Pediatric Otorhinolaryngology
|
March 24, 2019
Otorhinolaryngological manifestations and delayed diagnosis in Kawasaki disease
M Rouault, A Coudert, R Hermann, et al.
Psychiatry Research
|
April 1, 1986
Simultaneous panic and depressive disorders: clinical and sleep EEG correlates
L Grunhaus, D Rabin, Y Harel, et al.
Journal of Structural Biology
|
July 1, 1995
Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin
H H Bauer, U Aebi, M Häner, et al.
The Pharmacogenomics Journal
|
January 13, 2006
The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine
R Hermann, J Borlak, U Munzel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 1998
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK)
S Leyvraz, M Bacchi, T Cerny, et al.
Page
of 24
Search research articles
Search
Showing results (111-120 of 237) with videos related to
Sort By:
Page
of 24
Journal of Computer-Aided Molecular Design
|
October 5, 2020
Covalent inhibitor reactivity prediction by the electrophilicity index-in and out of scope
Markus R Hermann, Alexander Pautsch, Marc A Grundl, et al.
Carcinogenesis
|
July 30, 1999
Strong nasal carcinogenicity and genotoxicity of 1-nitroso-4-methylpiperazine after low dose inhalation in rats
R G Klein, P Schmezer, R Hermann, et al.
The Journal of Physical Chemistry Letters
|
January 18, 2020
Small-Angle X-ray Scattering Curves of Detergent Micelles: Effects of Asymmetry, Shape Fluctuations, Disorder, and Atomic Details
Miloš T Ivanović, Markus R Hermann, Maciej Wójcik, et al.
Applied and Environmental Microbiology
|
June 1, 2000
Methods for intense aeration, growth, storage, and replication of bacterial strains in microtiter plates
W A Duetz, L Rüedi, R Hermann, et al.
Bollettino Chimico Farmaceutico
|
July 1, 1995
HPLC method for the quantitation of cispentacin enantiomers in rat urine
M Zanol, R Hermann, A Bernareggi, et al.
International Journal of Pediatric Otorhinolaryngology
|
March 24, 2019
Otorhinolaryngological manifestations and delayed diagnosis in Kawasaki disease
M Rouault, A Coudert, R Hermann, et al.
Psychiatry Research
|
April 1, 1986
Simultaneous panic and depressive disorders: clinical and sleep EEG correlates
L Grunhaus, D Rabin, Y Harel, et al.
Journal of Structural Biology
|
July 1, 1995
Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin
H H Bauer, U Aebi, M Häner, et al.
The Pharmacogenomics Journal
|
January 13, 2006
The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine
R Hermann, J Borlak, U Munzel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 1998
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK)
S Leyvraz, M Bacchi, T Cerny, et al.
Page
of 24